AIKI

AIkido Pharma Inc

Halal Rating :
Comfortable
Last Price $1.13 Last updated:
Market Cap -
7D Change 8.65%
1 Year Change -46.45%

Company Overview

Exchange
Next Earnings Date

AIkido Pharma Inc is a biotechnology company focused on developing small-molecule anti-cancer therapeutics. The company's strategy involves acquiring and developing a diversified portfolio of early-stage technologies, with a particular focus on novel oncology drugs and treatments. They operate through licensing agreements and partnerships with various research institutions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $4.04m $7.24m - - 0.00% 0.00%
June 30, 2024 $6.17m $8.91m - - 0.00% 0.00%
March 31, 2024 $1.37m $4.17m - - 0.00% 0.00%

Company Impact

Help us evaluate AIkido Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates